Elmedina Jahic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elmedina Jahic has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Almir Fajkic
Department of Pathophysiology , University of Sarajevo , Faculty of Medicine , Sarajevo , Bosnia and Herzegovina
1 shared publication - Amela Dervišević
University of Sarajevo, Sarajevo, Bosnia and Herzegovina
1 shared publication - Asija Zaciragic
University of Sarajevo, Sarajevo, Bosnia and Herzegovina
1 shared publication - Enisa Ademovic
University of Sarajevo Faculty of Medicine, Department of Epidemiology and Biostatistics, Sarajevo, Bosnia and Herzegovina
1 shared publication - Lejla Dervišević
Department of Human Anatomy, Faculty of Medicine, University of Sarajevo, 71 000 Sarajevo, Bosnia and Herzegovina
1 shared publication - Zurifa Ajanović
Department of Human Anatomy, Faculty of Medicine, University of Sarajevo, 71000 Sarajevo, Bosnia and Herzegovina
1 shared publication
Latest Publications
- Open Access
- 5 September 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (3) , 183-191
Systemic Immune-inflammation Index in Evaluation of Inflammation in Rheumatoid Arthritis Patients
To evaluate the systemic immune-inflammation (SII) index in patients with rheumatoid arthritis (RA) stratified by systemic inflammatory status. Seropositive patients with RA (n=58) were divided into two groups based on serum hs-C-reactive protein (hs-CRP) levels: RA patients with hs-CRP levels of at or 3 mg/L or above (high systemic inflammatory status; n=38) and RA patients with hs-CRP levels of less than 3 mg/L (low systemic inflammatory status; n=20). The control group comprised 31 healthy individuals. Blood samples were tested for the next parameters: leukocytes, neutrophilic granulocytes, lymphocytes, thrombocytes [platelet (PLT)], high-sensitivity hs-CRP, sed rate [erythrocyte sedimentation rate (ESR)], neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR). The SII index was derived as Neu x PLT/Lym. In patients with RA, the SII index was elevated compared with that of healthy individuals and positively correlated with hs-CRP, erythrocyte sedimentation rate, NLR, MLR, PLR, tender joint count, and swollen-to-tender joint count ratio. Patients with RA who had hs-CRP levels of 3 mg/L above exhibited a statistically significant increase in the SII compared with those with hs-CRP levels below 3 mg/L. Additionally, within the cohort of RA patients with hs-CRP levels at or above 3 mg/L, a positive correlation was found between the SII index and both NLR and PLR. The SII index was positively correlated with NLR, MLR, and PLR in RA patients with hs-CRP levels below 3 mg/L. The cut-off point of the SII index for distinguishing between RA cases with hs-CRP levels 3 mg/L and those with hs-CRP levels 3 mg/L or higher was ≥323.4, with a sensitivity of 77.6% and a specificity of 54.8%. The serum SII index can be a potentially useful marker for evaluating the inflammatory process and clinical progression of RA.
- 5 September 2024
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (3) , 183-191
Open AccessSystemic Immune-inflammation Index in Evaluation of Inflammation in Rheumatoid Arthritis Patients
To evaluate the systemic immune-inflammation (SII) index in patients with rheumatoid arthritis (RA) stratified by systemic inflammatory status. Seropositive patients with RA (n=58) were divided into two groups based on serum hs-C-reactive protein (hs-CRP) levels: RA patients with hs-CRP levels of at or 3 mg/L or above (high systemic inflammatory status; n=38) and RA patients with hs-CRP levels of less than 3 mg/L (low systemic inflammatory status; n=20). The control group comprised 31 healthy individuals. Blood samples were tested for the next parameters: leukocytes, neutrophilic granulocytes, lymphocytes, thrombocytes [platelet (PLT)], high-sensitivity hs-CRP, sed rate [erythrocyte sedimentation rate (ESR)], neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR). The SII index was derived as Neu x PLT/Lym. In patients with RA, the SII index was elevated compared with that of healthy individuals and positively correlated with hs-CRP, erythrocyte sedimentation rate, NLR, MLR, PLR, tender joint count, and swollen-to-tender joint count ratio. Patients with RA who had hs-CRP levels of 3 mg/L above exhibited a statistically significant increase in the SII compared with those with hs-CRP levels below 3 mg/L. Additionally, within the cohort of RA patients with hs-CRP levels at or above 3 mg/L, a positive correlation was found between the SII index and both NLR and PLR. The SII index was positively correlated with NLR, MLR, and PLR in RA patients with hs-CRP levels below 3 mg/L. The cut-off point of the SII index for distinguishing between RA cases with hs-CRP levels 3 mg/L and those with hs-CRP levels 3 mg/L or higher was ≥323.4, with a sensitivity of 77.6% and a specificity of 54.8%. The serum SII index can be a potentially useful marker for evaluating the inflammatory process and clinical progression of RA.